Proprio

Series-B+
propriovision.com Biotech & Healthcare
Total Funding $43M
Latest Round $43M Series-B+
Last Announced Jul 27, 2023
Investors Undisclosed
Decision Makers 2 Verified

About Proprio

Proprio is a technology company modernizing the way we predict, perform, and perfect surgery through the combination of physician expertise and immersive, intelligent technology.

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-B+
Global Headquarters Undisclosed
Tracked Since Oct 1, 2026

Web & Domain Identity

Official Website propriovision.com
Domain Registered Date Jan 25, 2018

Social & Network Presence

X / Twitter Profile @Proprio_Vision (428 followers) Created on Jul 2019
LinkedIn Corporate Not linked

Company Milestones & Timeline

3 Events
  1. Capital Raise

    Raised $43,000,000 · Series-B+

    fundraisingfox.com

  2. Milestone

    X account created (@Proprio_Vision)

    428 followers

  3. Milestone

    Website domain registered

    propriovision.com

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Proprio.

Funding History

1 Round
Series-B+ · Jul 27, 2023

Founders & Leadership

3

computer vision specialist James Youngquist

co-founder

Work email & phone locked Unlock →

Gabriel Jones

CEO and co-founder

Work email & phone locked Unlock →

Samuel Browd

co-founder

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts